BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32420260)

  • 1. Not all adrenal incidentalomas require biochemical testing to exclude pheochromocytoma: Mayo clinic experience and a meta-analysis.
    Gruber LM; Strajina V; Bancos I; Murad MH; Dy BM; Young WF; Farley DR; Lyden ML; Thompson GB; McKenzie TJ
    Gland Surg; 2020 Apr; 9(2):362-371. PubMed ID: 32420260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?
    Sane T; Schalin-Jäntti C; Raade M
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2077-83. PubMed ID: 22492870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study.
    Buitenwerf E; Korteweg T; Visser A; Haag CMSC; Feelders RA; Timmers HJLM; Canu L; Haak HR; Bisschop PHLT; Eekhoff EMW; Corssmit EPM; Krak NC; Rasenberg E; van den Bergh J; Stoker J; Greuter MJW; Dullaart RPF; Links TP; Kerstens MN
    Eur J Endocrinol; 2018 May; 178(5):431-437. PubMed ID: 29467230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Preoperative Biochemical Testing for Pheochromocytoma Necessary for All Adrenal Incidentalomas?
    Jun JH; Ahn HJ; Lee SM; Kim JA; Park BK; Kim JS; Kim JH
    Medicine (Baltimore); 2015 Nov; 94(45):e1948. PubMed ID: 26559265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Accuracy of Computed Tomography to Exclude Pheochromocytoma: A Systematic Review, Meta-analysis, and Cost Analysis.
    Buitenwerf E; Berends AMA; van Asselt ADI; Korteweg T; Greuter MJW; Veeger NJM; Links TP; Dullaart RPF; Kerstens MN
    Mayo Clin Proc; 2019 Oct; 94(10):2040-2052. PubMed ID: 31515105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma.
    Canu L; Van Hemert JAW; Kerstens MN; Hartman RP; Khanna A; Kraljevic I; Kastelan D; Badiu C; Ambroziak U; Tabarin A; Haissaguerre M; Buitenwerf E; Visser A; Mannelli M; Arlt W; Chortis V; Bourdeau I; Gagnon N; Buchy M; Borson-Chazot F; Deutschbein T; Fassnacht M; Hubalewska-Dydejczyk A; Motyka M; Rzepka E; Casey RT; Challis BG; Quinkler M; Vroonen L; Spyroglou A; Beuschlein F; Lamas C; Young WF; Bancos I; Timmers HJLM
    J Clin Endocrinol Metab; 2019 Feb; 104(2):312-318. PubMed ID: 30383267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, imaging and biochemical presentation of cystic pheochromocytomas.
    Dogra P; Navin PJ; McKenzie TJ; Foster T; Dy B; Lyden M; Young WF; Bancos I
    Clin Endocrinol (Oxf); 2023 Jan; 98(1):32-40. PubMed ID: 35445428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study.
    Halefoglu AM; Bas N; Yasar A; Basak M
    Eur J Radiol; 2010 Mar; 73(3):643-51. PubMed ID: 19167179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Quantitative MRI and CT Washout Analysis for Differentiation of Adrenal Pheochromocytoma From Adrenal Adenoma.
    Schieda N; Alrashed A; Flood TA; Samji K; Shabana W; McInnes MD
    AJR Am J Roentgenol; 2016 Jun; 206(6):1141-8. PubMed ID: 27011100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Value of Unenhanced CT Attenuation and CT Histogram Analysis in Differential Diagnosis of Adrenal Tumors.
    Szász P; Kučera P; Čtvrtlík F; Langová K; Hartmann I; Tüdös Z
    Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33182333
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas.
    Motta-Ramirez GA; Remer EM; Herts BR; Gill IS; Hamrahian AH
    AJR Am J Roentgenol; 2005 Sep; 185(3):684-8. PubMed ID: 16120918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental Adrenal Nodules in Patients Without Known Malignancy: Prevalence of Malignancy and Utility of Washout CT for Characterization-A Multiinstitutional Study.
    Corwin MT; Badawy M; Caoili EM; Carney BW; Colak C; Elsayes KM; Gerson R; Klimkowski SP; McPhedran R; Pandya A; Pouw ME; Schieda N; Song JH; Remer EM
    AJR Am J Roentgenol; 2022 Nov; 219(5):804-812. PubMed ID: 35731098
    [No Abstract]   [Full Text] [Related]  

  • 13. Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.
    Park SH; Kim MJ; Kim JH; Lim JS; Kim KW
    Korean J Radiol; 2007; 8(4):328-35. PubMed ID: 17673844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of quantitative parameters for distinguishing pheochromocytoma from other adrenal tumors.
    Ohno Y; Sone M; Taura D; Yamasaki T; Kojima K; Honda-Kohmo K; Fukuda Y; Matsuo K; Fujii T; Yasoda A; Ogawa O; Inagaki N
    Hypertens Res; 2018 Mar; 41(3):165-175. PubMed ID: 29348428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal Adenoma and Pheochromocytoma: Comparison of Multidetector CT Venous Enhancement Levels and Washout Characteristics.
    Northcutt BG; Trakhtenbroit MA; Gomez EN; Fishman EK; Johnson PT
    J Comput Assist Tomogr; 2016; 40(2):194-200. PubMed ID: 26978001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-energy CT for characterization of the incidental adrenal mass: preliminary observations.
    Gnannt R; Fischer M; Goetti R; Karlo C; Leschka S; Alkadhi H
    AJR Am J Roentgenol; 2012 Jan; 198(1):138-44. PubMed ID: 22194489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal masses: CT characterization with histogram analysis method.
    Bae KT; Fuangtharnthip P; Prasad SR; Joe BN; Heiken JP
    Radiology; 2003 Sep; 228(3):735-42. PubMed ID: 12954893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, Biochemical, and Radiological Characteristics of a Single-Center Retrospective Cohort of 705 Large Adrenal Tumors.
    Iñiguez-Ariza NM; Kohlenberg JD; Delivanis DA; Hartman RP; Dean DS; Thomas MA; Shah MZ; Herndon J; McKenzie TJ; Arlt W; Young WF; Bancos I
    Mayo Clin Proc Innov Qual Outcomes; 2018 Mar; 2(1):30-39. PubMed ID: 30225430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDCT of adrenal masses: Can dual-phase enhancement patterns be used to differentiate adenoma and pheochromocytoma?
    Northcutt BG; Raman SP; Long C; Oshmyansky AR; Siegelman SS; Fishman EK; Johnson PT
    AJR Am J Roentgenol; 2013 Oct; 201(4):834-9. PubMed ID: 24059372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma?
    Patel J; Davenport MS; Cohan RH; Caoili EM
    AJR Am J Roentgenol; 2013 Jul; 201(1):122-7. PubMed ID: 23789665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.